American Journal of Clinical Oncology-Cancer Clinical Trials

Papers
(The median citation count of American Journal of Clinical Oncology-Cancer Clinical Trials is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Efficacy and Safety of Pegylated Filgrastim as Primary Prophylaxis Following Pediatric Dose-intensive Chemotherapy61
Death From Infection Among Patients Living With Cancer42
Cardiac Angiosarcomas24
The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma24
The Impact of Patient, Disease, and Social Determinants of Health on Receipt of Nonoperative Management for Patients With Rectal Adenocarcinoma18
Validation of Spanish-Language Surveys Utilized for the Navigator-Assisted Hypofractionation (NAVAH) Program to Aid Hispanic-American Breast Cancer Patients17
Pharmacokinetics-Pharmacodynamics Modeling and Evaluation of Tumor Response to Bortezomib Proteasome Inhibitor in Waldenstrom Macroglobulinemia16
Clinical Outcomes and Safety Profile of Adagrasib in KRAS G12C-Mutated Solid Tumors16
Does Examined Lymph Node Count Influence Survival in Surgically Resected Early‑stage Pulmonary Typical Carcinoid Tumors?14
Nomogram Predicting Grade ≥2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy14
Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers14
Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer12
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer11
Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer11
Third-line Treatment for Metastatic Triple-negative Breast Cancer10
Lack of Impact of Expansion Size From Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Fractionated Radiotherapy for WHO Grade 1 Meningiomas10
Heart Disease Mortality After Primary Cancer Surgery in the United States10
Efficacy and Safety of Camrelizumab Plus Apatinib for Esophageal Squamous Cell Carcinoma10
The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer10
Beyond the Clinic9
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy9
Patient Navigation for Cancer Care in Sub-Saharan Africa9
Hypofractionated Radiation Therapy9
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer9
Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus9
Temporality and Patterns of Metastatic Recurrence in Node-Positive Breast Cancer Following Trimodality Therapy8
Prospective Validation of An Inpatient Metastatic Spine Neoplasm Score To Assess the Optimal Radiation Therapy Intervention Modality8
The Effect of Biomarkers on Clinical Trial Risk in Gastric Cancer8
Outcome Predictors of Hardware Complications in Head and Neck Free Flap Reconstruction8
Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites8
ACR–ACNM–ARS–SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride7
The Role of Lactate Metabolism in Tumors7
The Role of the Quality of Relationship in Couples Facing Treatment for Breast Cancer7
Impact of Maximum Point Dose Within the Planning Target Volume on Local Control of Nonsmall Cell Lung Cancer Treated With Stereotactic Body Radiotherapy7
Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases7
SBRT vs. Y907
Treatment of Cutaneous Adnexal Carcinoma With Radiotherapy7
Crossover in Adjuvant Trastuzumab Trials7
A Meta-analysis on Effects of Chimeric Antigen Receptor T-cell Therapy in Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia7
Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 20157
A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell Carcinoma7
Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies7
Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy6
Early Cancer Screening Impressions of African-American Breast Cancer Patients Enrolled on the Navigator-Assisted Hypofractionation (NAVAH) Trial6
Accuracy of Medical Oncology Prognosis for Metastatic Cancer Patients Evaluated for Enrollment Onto an Ongoing Randomized Clinical Trial6
ACR–ARS Practice Parameter for Radiation Oncology6
Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas6
Incidence and Risk of Second Primary Malignancies After Treatment for Papillary Thyroid Cancer5
Sacituzumab Govitecan-hziy in Breast Cancer5
Evaluating N-acetylcysteine as a Protective Agent Against Chemotherapy-induced Neuropathy in Breast Cancer5
Therapeutic Evaluation of Induction Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma With Low-risk N Stage5
Quantification of Postdiagnosis Cancer Patient Navigation5
Why Basic Science Education Matters in Radiation Oncology5
Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma Patients5
Early Experience With Biologically Effective Dose-Comparable Short-Course Whole Brain Radiation Therapy for Metastatic Intracranial Disease5
Intramedullary Nailing Versus Compound Plate Osteosynthesis in Pathologic Diaphyseal Humerus Fractures5
Mortality Patterns of Esophageal Cancer in the United States5
Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy5
Overactive Bladder Symptoms in Cancer Patients Undergoing Chemotherapy5
Laparoscopic Versus Abdominal Radical Hysterectomy for Cervical Cancer5
Treatment of Cancer Pain5
Impact of Time From Diagnosis to Treatment Start on the Outcomes of Patients With Nonmetastatic Anal Squamous Cell Carcinoma5
The Prognostic Impact of Radiotherapy Delays in Oropharynx Carcinoma and the Role of p16 Status5
Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors5
Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer5
Physician Assessment of ChatGPT and Bing Answers to American Cancer Society’s Questions to Ask About Your Cancer5
Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer5
Brachial Plexus Constraints in Two-Fraction Spine Stereotactic Body Radiation Therapy5
Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation Practices for Node-negative Intact Breast Cancer5
The microRNA-34 Family and Its Functional Role in Lung Cancer4
Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non–Small Cell Lung Cancer4
Laparoscopic Versus Abdominal Radical Hysterectomy4
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients4
The Balance and Imbalance of Microbial Communities4
Evaluating the Safety and Efficacy of Adding Liver-Directed Radiation Therapy to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma4
The Best Interest4
Does Current Training in Radiation Oncology Prepare Radiation Oncologists to Optimally Manage Patients With Head and Neck Cancer?4
Targeted and Chemo-Free Approaches in HER2-Positive Early Breast Cancer4
Preoperative Computed Tomography Radiomics Analysis for Predicting Receptors Status and Ki-67 Levels in Breast Cancer4
Metaplastic Breast Carcinoma4
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors4
Predicting Factors for a Favorable Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer4
Long-Term Outcomes After Abdominal Radiation for Wilms Tumor4
Deep Learning-Based Risk Factor Analysis for Accurate Prediction of Lung Cancer in High-Risk Populations4
Efficacy and Safety of Probiotics as Adjunctive Therapy in Cancer Treatment4
Long COVID in Cancer4
Navigator-Assisted Hypofractionation (NAVAH) Phase I Clinical Trial of Breast Cancer Patients4
Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer3
The Biology and Systemic Treatments Influence Survival in Advanced Gastrointestinal Cancers While the Controlled Trial of Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) Found That Surgical Re3
Executive Summary of the American Radium Society Appropriate Use Criteria3
Primary Synovial Sarcoma of the Abdomen and Pelvis3
Impact of Chemotherapy on Financial Toxicity in African American Breast Cancer Patients3
Practice Patterns of Surveillance in Sentinel Lymph Node-Positive Malignant Melanoma3
A Novel Nomogram for Predicting Breast Cancer–specific Survival in Male Patients3
Evaluation of Control Arm Quality in Recent Radiation Oncology Randomized Clinical Trials3
Prognostics of Systemic Malignancy ICD-O Topography and Morphology Types on Brain Metastases3
A Systematic Review of Conversion to Resectability in Unresectable Metastatic Colorectal Cancer Chemotherapy Trials3
Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer3
Prognostic Value of Multiparameter Biomarkers in Pleural Effusion of Patients With Non-small Cell Lung Cancer for Predicting Survival Outcomes3
Proceedings of the American Radium Society® 104th Annual Meeting3
Clinicopathological Characteristics, Survival and Prognostic Factors in Gastrointestinal Large Cell Neuroendocrine Carcinoma3
Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer3
H-Index and Promotion in Academic Radiation Oncology3
Five Fraction External Beam Partial Breast Irradiation3
Prognostic Value of Lymph Node Parameters in Elderly Patients With Stage III Serous Ovarian Cancer Based on Competing Risk Model3
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma3
Geospatial Mapping of Head and Neck Cancer Research3
Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation3
Prevalence and Development of Cachexia Before and After Diagnosis of Non–small Cell Lung Cancer3
Advancements in Diagnosis and Multimodal Treatment Strategies for Retroperitoneal Tumors3
Beyond Treatment3
Comorbidity and Risk of Complications and Readmissions Following Surgery for Patients With Renal Cell Carcinoma in the Military Health System3
Social Determinants of Health in Oncology3
Racial and Gender Differences in Patient Satisfaction Scores Among Oncologists3
How Did We Get Here? The Progression From Frame-Based to Frameless Intracranial Stereotactic Radiosurgery3
The Concerning Disaggregation of Gender and Racial/Ethnicity Disparity Investigation at Recent ASCO Annual Meetings3
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer3
Efficacy and Safety of Antibody Drug Conjugates in Previously Treated Hormone Receptor Positive HER2 Negative (or Low) Metastatic Breast Cancer–A Systematic Review and Meta-Analysis3
ACR–ABS–ACNM–ARS–SIR–SNMMI Practice Parameter for Radioembolization of Liver Malignancies2
Regional Variation in Access to Oncologic Care and Racial Disparities Among Cervical Cancer Patients2
Prognostic Relevance of Negative Lymph Node Count in Resected Stage I–IIIa Small-cell Lung Cancer2
Flap Reconstruction Results in Longer Overall Treatment Time in Patients Treated With Surgery and Adjuvant Radiotherapy for Carcinoma of the Oral Cavity and Larynx2
Advancing MRD Detection in Multiple Myeloma2
Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation2
Racial Disparities in Endometrial Cancer Clinical Trial Representation2
Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker Versus Surgical Clips for Targeting Breast Cancer Radiotherapy2
Efficacy and Toxicity of Combined Inhibition of EGFR and VEGF in Patients With Advanced Non–small Cell Lung Cancer Harboring Activating EGFR Mutations2
Development and Validation of Palmitoylation-Related Genes in the Prognostic and Immunologic Characterization of Lung Adenocarcinoma2
Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography2
Dual Inhibition of HER2 and VEGF Pathways in Breast Cancer2
Matched Cohort Analysis of Ultra-hypofractionated Versus Standard Fractionation Preoperative Radiation Therapy for Soft Tissue Sarcoma2
Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases2
The Significance of the Redox Gene in the Prognosis and Therapeutic Response of Glioma2
Meta-analysis of Therapeutic Approaches in Acute Myeloid Leukemia2
Predictors of an Academic Career in Radiation Oncology 5 to 10 Years After Residency2
Bombarding Oligoprogression2
Sentinel Node Navigation Surgery for Early Gastric Cancer2
Accelerated Partial Breast Irradiation2
Efficacy of Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer2
An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation2
Standard Versus Extended Pelvic Lymphadenectomy in Patients With Bladder Cancer2
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy2
Correlation of Lung Immune Prognostic Index With Efficacy of PD-1/PD-L1 Inhibitor Combined With Chemotherapy and Prognosis in Patients With Advanced Non–Small Cell Lung Cancer2
Complications of Implant-Based Reconstruction and Postmastectomy Radiation in the Era of Adjuvant CDK4/6 Inhibitors2
Real-world Safety of Concurrent Pembrolizumab and Radiotherapy in Triple-negative Breast Cancer2
Phase 1 Study of Bortezomib, Fludarabine, and Melphalan, With or Without Total Marrow Irradiation, as Allogeneic Hematopoietic Stem Cell Transplant Conditioning for High-risk or Relapsed/Refractory Mu2
Transcranial Magnetic Stimulation (TMS) in Cancer Care2
Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast Cancer2
Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases2
The Brown University Oncology Group Experience With FOLFOX + Nab-paclitaxel [FOLFOX-A] for Metastatic and Locally Advanced Pancreatic, BrUOG-292 and BrUOG-3182
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy2
The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal Toxicity2
Prognostic Value of Pretreatment Serum Carcinoembryonic Antigen Level in 1130 Patients With Non-small Cell Lung Cancer2
The Role of Social Determinants of Health in the Receipt of Systemic Treatment for Metastatic Melanoma2
Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors2
Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum2
A Preliminary Study of Immediate Intraperitoneal Chemotherapy for Stage III Colorectal Cancer2
Long-term Locoregional Control With Unilateral Radiation for AJCC-7 T1-2N2b Tonsillar Cancer2
The Cost of Simplicity for Early-stage Breast Cancer Treatment2
Temporal Trends and Predictors of Opioid Use Among Older Patients With Cancer2
Assessing the Rate and Quality of Breast Cancer Treatment Following Initial Diagnosis2
Correspondence Letter to “Does Current Training in Radiation Oncology Prepare Radiation Oncologists to Optimally Manage Patients With Head and Neck Cancer?”2
Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy: Erratum2
KRAS Mutations in Cancer2
ACR–ARS Practice Parameter for the Performance of Stereotactic Body Radiation Therapy2
Circulating DNA in Rectal Cancer to Unravel the Prognostic Potential for Radiation Oncologist2
The Impact of Race and Ethnicity on Location and Delivery of Palliative Radiotherapy2
Censoring Analysis of the INvestigating VorasiDenib In GliOma (INDIGO) Phase III Randomized Controlled Trial1
Management Strategies and Outcomes in Primary Liver Angiosarcoma1
Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2–Positive Metastatic Breast Cancer in Manitoba1
Efficacy and Safety of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma1
Cardiovascular Risk Profile of Nivolumab Anti-cancer Therapy1
ACR–ARS Practice Parameter for the Performance of Total Body Irradiation1
Decision-making for Subsequent Therapy for Patients With Recurrent or Advanced Endometrial Cancer Based on the Platinum-free Interval1
Efficacy and Safety of Abemaciclib in Combination With Endocrine Therapy for HR+/HER2− Advanced or Metastatic Breast Cancer1
ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer1
Research Progress of SBRT Combined With Immunotherapy in Locally Advanced Head and Neck Cancer1
Risk Factors for Recurrence and the Role of Radiotherapy in Low-grade Myofibroblastic Sarcoma1
Effects of Whole Pelvic Radiotherapy on the Distribution of Lymphocyte Subpopulations in Prostate Cancer Patients1
Outcomes of Patients With Esophageal and Gastric Carcinoma at a Safety-net Health Care System1
Global Trends in Childhood Acute Lymphoblastic Leukemia Burden and Quality of Care Inequalities Across Regions, 1990 to 20211
Proceedings of the American Radium Society® 106th Annual Meeting1
Empowering Self-advocacy for Breast Health1
Risk Factors for Postoperative Venous Thromboembolism in Patients With Gynecologic Malignancies1
ACR–ARS Practice Parameter for Communication1
Executive Summary of the American Radium Society Appropriate Use Criteria for the Use of Esophageal Stents in Patients With Esophageal Cancer1
Wilms’ Tumor 1-Associating Protein Promotes Nonsmall-Cell Lung Cancer Through the Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 51
Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant1
Impact of Sequencing of Treatment Modalities on Survival in Nonmetastatic Hepatocellular Carcinoma1
Clinicopathologic Features of Noninvasive Inverted Urothelial Papillary Tumor1
Predicting and Optimizing Synergistic Drug Combinations for Breast Cancer Treatment Using Machine Learning1
Stereotactic Radiosurgery for Vestibular Schwannoma With Radiographic Brainstem Compression1
Hospital Price Transparency Rule Exposes Muddied Costs for Head and Neck Radiotherapy in One State1
Prostate Brachytherapy With Cs-1311
Effect of Continuous Nutritionist-led Guidance on Bowel Preparation in Patients Undergoing Prostate Stereotactic Body Radiation Treatment With Endorectal Spacing1
Rituximab as a Therapeutic Strategy in Hemophagocytic Lymphohistiocytosis: Efficacy, Outcomes, and Survival—Insights From a Systematic Review1
Statewide Social Vulnerability Index (SVI) in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma1
Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma1
Comprehensive Analysis of Conditional Survival in Radiation-treated Patients With Gynecologic Malignancies Using the SEER Database1
AI Prognostication in Nonsmall Cell Lung Cancer1
A Phase II Trial to Assess the Evolution of the KRAS Mutation Load by Liquid Biopsy in Patients With Resectable Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant NALIRIFOX1
Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation1
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy1
Maintenance Therapy in Acute Myeloid Leukemia1
ACR-ABS-ASTRO Practice Parameter for the Performance of Low-Dose-Rate Brachytherapy1
Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer1
Stereotactic Body Radiotherapy and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer1
Nonoperative Management Following Complete Response in Rectal Cancer After Short-course Radiation Therapy and Consolidation Chemotherapy1
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian Cancer1
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non–Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy1
Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes1
Advancements in Cutaneous T-Cell Lymphoma Treatment1
Success of Ultra-low Dose Radiation Therapy for Primary Cutaneous B-cell Lymphoma1
Comprehensive Understanding and Evolutional Therapeutic Schemes for Pseudomyxoma Peritonei1
Letter to Editor on Qureshi et al. Efficacy and Safety of Abemaciclib in Combination with Endocrine Therapy for HR+/HER2− Advanced or Metastatic Breast Cancer a Systematic Review and Meta-Analysis, Am1
Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction1
Impact of Interruptions in Chemotherapy on Survival for Patients With Metastatic or Recurrent Cervical Cancer1
Efficacy and Safety of Lenvatinib in Combination With Other Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma1
Genetic Alterations in NSCLC1
Advancements in NSCLC1
Impact of Minimal Residual Diseases Status and Depth of Response on Survival Outcomes in Blinatumomab-Treated Acute Lymphoblastic Leukemia1
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Extrahepatic Cholangiocarcinoma1
Bevacizumab Combination Therapy Versus Standard Chemotherapy for Ovarian Cancer in Shorter and Longer Follow-Up Duration1
Optimizing Natural Killer Cellular Therapy in Acute Myeloid Leukemia1
Metabolic Plasticity in Prostate Cancer1
Predictors of Survival in Patients With Hepatocellular Cancer Receiving Atezolizumab and Bevacizumab1
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer1
Safety and Efficacy of Trastuzumab Deruxtecan for Metastatic HER2+ and HER2-low Breast Cancer1
Effect of Somatosensory Interaction Transcutaneous Electrical Acupoint Stimulation on Cancer-related Fatigue and Immunity1
A Chitosan-Coated Chamomile Microparticles Formulation to Prevent Radiodermatitis in Breast1
A Review of Endocrine Therapy in Early-stage Breast Cancer1
Targeted Therapies in Non–Small Cell Lung Cancer1
The Impact of Psychedelic Drugs on Anxiety and Depression in Advanced Cancer or other Life-threatening Disease1
Pretreatment Characteristics of Carcinoid Tumors of the Lung Which Predict Aggressive Behavior: Erratum1
Modifiable Lifestyle Risk Factors in Adult Survivors of Childhood Cancer1
0.278804063797